Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_assertion type Assertion NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_head.
- NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_assertion description "[Consistent with this reasoning, we found that the MGMT-expressing glioblastoma cell lines exhibiting an unmethylated MGMT promoter that were pretreated with decitabine became significantly more sensitive to temozolomide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_provenance.
- NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_assertion evidence source_evidence_literature NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_provenance.
- NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_assertion SIO_000772 24568970 NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_provenance.
- NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_assertion wasDerivedFrom befree-2016 NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_provenance.
- NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_assertion wasGeneratedBy ECO_0000203 NP1158028.RAodvoc5CshIKGtBwB10tawFNXRHWSkpIteP87rjjdpBI130_provenance.